Evolution of the Average Target: GlaxoSmithKline Pakistan Limited

Evolution of the Target Price: GlaxoSmithKline Pakistan Limited

Changes in Analyst Recommendations: GlaxoSmithKline Pakistan Limited

32995822312c30.LfIGP7g9CjFMLvujrxkyDUWEfIF5kPPulTU_TooU_9A.bJlKW-BpTEAKSouU_Sh0WzP1RLQA0pGa9kYSDcdBseJGhn8OlURZen5hiA~07dbff49ca238cfa45a3857dfc79d899

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +47.42%
+4.75%
+0.84%
+4.39%
-1.41%
-2.99%
+27.25%
-11.57%
+2.95%
+7.72%
Average +7.94%
Weighted average by Cap. +3.37%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
345.96PKR
Average target price
510.00PKR
Spread / Average Target
+47.42%
High Price Target
510.00PKR
Spread / Highest target
+47.42%
Low Price Target
510.00PKR
Spread / Lowest Target
+47.42%

Analyst Consensus Detail

Consensus revision (last 18 months)

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
345.96PKR
Average target price
510.00PKR
Spread / Average Target
+47.42%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GLAXO Stock
  4. Consensus GlaxoSmithKline Pakistan Limited